New biological options in airways disease


New biological options in airways disease was last modified: April 24th, 2018 by Publicrelations

New biological options in airways disease

May 2, 2018

Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun Street Nedlands

Register For Event

Join us for a presentation on new biological options in airways disease presented by visiting speaker Professor Ian Pavord from the University of Oxford.

Wednesday 2nd May
12.30pm lunch
1.00pm – 2.00pm presentation

McCusker Auditorium
Harry Perkins Institute of Medical Research, QEII Medical Centre, 6 Verdun Street Nedlands

RSVP to sarah.cermak@resphealth.uwa.edu.au for catering purposes.

Professor Pavord is an internationally renowned respiratory medicine researcher who has had 18 years experience as an NHS Consultant in Respiratory Medicine at Glenfield Hospital in Leicester, before taking up the post as the first statutory Professor of Respiratory Medicine in Oxford in 2013.

His main clinical and research interests are in inflammatory airway diseases (asthma, COPD, chronic cough). He pioneered the use of non-invasive measures of airway inflammation in the assessment of these conditions and used these techniques to identify a number of clinically important phenotypes of inflammatory airway disease. He played a lead role in the clinical development of three of the most promising new treatments for severe airway disease.

In Oxford Professor Pavord runs a special airway clinic for patients with more severe airways disease. In the past he ran one of the leading cough clinics in the UK. In 2016 Professor Pavord was awarded The ERS Gold Medal in Asthma in recognition of his outstanding contribution in the field of asthma research.

New biological options in airways disease was last modified: April 24th, 2018 by Publicrelations

New biological options in airways disease was last modified: April 24th, 2018 by Publicrelations